Business Context and Reporting Period
This Form 6-K filing by Tower Semiconductor Ltd. (TSEM) covers the period ending February 21, 2007. The filing primarily announces a strategic business development rather than reporting periodic financial results.
Key Financial Metrics
The filing text does not provide specific financial metrics for Tower Semiconductor Ltd., including revenue, profit, cash flow, margins, debt, or liquidity. The document contains no financial tables or numerical data regarding the registrant's performance.
Contextual financial data is provided only for the customer, e2v Technologies PLC, which reported sales of GBP 112 million for the year ended March 31, 2006.
Material Changes and Strategic Developments
- New Supplier Agreement: e2v Technologies PLC has selected Tower Semiconductor as its supplier of choice for CMOS Image Sensor (CIS) devices.
- Production Details: Manufacturing will occur at Tower's advanced Fab2 facility using the CIS 0.18 micron process.
- Project Scope: The partnership currently focuses on ten key development projects aimed at creating "System on a Chip" sensors for industrial and medical applications.
- Market Growth: The targeted medical and industrial imaging markets are noted to be growing at annual rates of 10-15%.
Management Commentary and Outlook
Management highlights a two-year joint development program between Tower and e2v's Grenoble facility as the foundation for this selection. Dr. Avi Strum, General Manager of Tower's CMOS image sensor product line, attributed the deal to Tower's technology breakthroughs and design innovations.
Jean-Philippe Lamarcq, Imaging Business Unit General Manager at e2v, cited Tower's state-of-the-art manufacturing process and unique stitching technology as key factors in the decision. Both parties anticipate a long-term business relationship.
Risks and Contingencies: The filing includes a Safe Harbor statement noting that forward-looking statements are subject to risks and uncertainties. It directs investors to the "Risk Factors" section of the most recent Annual Report on Form 20-F for a complete discussion of potential risks.
Key Facts for Investor Verification
- Verify the expected revenue contribution from the ten development projects with e2v in future quarterly reports.
- Confirm the utilization rates of Fab2 and the specific yield performance of the 0.18 micron CIS process.
- Review the "Risk Factors" in the latest Form 20-F to understand potential impacts on the forward-looking statements made in this press release.
- Monitor the growth trajectory of the medical and industrial imaging sectors to validate the 10-15% annual growth rate cited by management.